The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 24, 2003

Filed:

May. 12, 1998
Applicant:
Inventors:

Scott W. Lowe, Cold Spring Harbor, NY (US);

Rachel R. Wallace-Brodeur, Huntington Station, NY (US);

Assignee:

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 3/300 ; A01K 6/7033 ; A01K 6/7027 ; C12N 5/06 ; A61K 4/900 ;
U.S. Cl.
CPC ...
G01N 3/300 ; A01K 6/7033 ; A01K 6/7027 ; C12N 5/06 ; A61K 4/900 ;
Abstract

A mouse expressing myc in B cells, because of defective function of one or more tumor suppressor genes, is useful for the testing of anti-lymphoma agents and for the testing of genes which may have an effect on the apoptotic pathway. Preferred embodiments include mice of genotypes E&mgr;-myc/p53 , E&mgr;-myc/Rb and E&mgr;-myc/p16 , and cells derived from lymphomas arising in these mice, wherein the cells may have undergone further genetic alteration. Mouse strains, lymphoma cells and cell lines of the invention can be used in methods to discover new anti-lymphoma agents, methods to characterize tumors, and to characterize genes which may affect the development of resistance to anti-tumor agents. Such methods are also part of the invention.


Find Patent Forward Citations

Loading…